Annovis Bio Inc is a clinical stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neuro degenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-04 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.260 | ||||||
| REV | 0 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ANVS | Annovis Bio | -5.48% | 173.7M |
Annovis Bio Company Questions & Answers
Q
How do I buy Annovis Bio (ANVS) stock?
A
You can purchase shares of Annovis Bio (AMEX: ANVS) through any online brokerage.
Q
Who are Annovis Bio's (ANVS) main competitors?
A
There are no as such competitors for Annovis Bio.
Q
What is the target price for Annovis Bio?
A
There is no analysis for Annovis Bio
Q
How much is Annovis Bio (ANVS) stock ?
A
The stock price for Annovis Bio (AMEX: ANVS) is $25.01 last updated Mon Apr 12 2021 19:59:43 GMT+0000 (Coordinated Universal Time).
Q
When is the next Annovis Bio (ANVS) dividend?
A
There are no upcoming dividends for Annovis Bio.
Q
When is Annovis Bio (AMEX:ANVS) reporting earnings?
A
Annovis Bio’s Q1 earnings are confirmed after-market from now on May 4, 2021.
Q
When is the upcoming split for ANVS?
A
There is no upcoming split for Annovis Bio.